EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S108
DOI: 10.1055/s-0044-1782925 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von E. Barbosa und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Aims
This systematic review and meta-analysis aimed to compare the efficacy and safety of endoscopic ultrasound-guided biliary drainage (EUS-BD) and endoscopic retrograde cholangiopancreatography-guided biliary drainage (ERCP-BD) as the initial approach for malignant biliary obstruction (MBO).
Methods
MEDLINE, Embase, and Cochrane databases were searched for randomized controlled trials comparing both techniques as the initial approach for MBO and reporting at least one of the outcomes of interest. The primary outcome was the stent patency. Secondary outcomes were technical and clinical success, reintervention, overall adverse events (AEs), post-procedure pancreatitis, cholangitis, tumor in/overgrowth, procedure time, length of hospital stay (LOS), and survival time. The risk ratio (RR) and mean difference (MD) were applied with their 95% confidence intervals (95% CIs) for dichotomous and continuous outcomes, respectively, using a random-effects model. We performed sensitivity analysis if I 2 ≥50% and subgroup assessments based on the etiology of the MBO (studies with>90% vs. studies with 90% of PC as the etiology of the MBO, there was a non-significant difference in the effect estimates between EUS-BD and ERCP-BD. However, in the subgroup of studies that included a lower rate of PC, EUS-BD showed a reduced risk of AEs and need for reintervention compared with ERCP-BD. Additionally, the subgroup analysis by the type of EUS-BD showed that only CDS-LAMS significantly reduced the procedure time and increased the technical success compared to ERCP-BD. [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ]
Conclusions
Although it demonstrated clinical efficacy comparable to ERCP-BD, EUS-BD resulted in a significantly lower risk of reintervention, post-procedure pancreatitis, tumor in/overgrowth rates, and reduced LOS. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Barbosa, E., Santo, P., Baraldo, S., Nau, A., & Meine, G. (2024). EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials. Endoscopy, 56(S 02 S 02), S108. https://doi.org/10.1055/s-0044-1782925
Vancouver
Barbosa E, Santo P, Baraldo S, Nau A, Meine G. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024;56(S 02 S 02):S108. doi:10.1055/s-0044-1782925
BibTeX
@article{Barbosa2024,
author = {Barbosa, E. and Santo, P. and Baraldo, S. and Nau, A. and Meine, G.},
title = {EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: a systematic review and meta-analysis of randomized controlled trials},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S108},
doi = {10.1055/s-0044-1782925}
}
EUVIMED